Join leading experts from the FDA, industry, and academia at CHI’s 18th Annual Immunogenicity & Bioassay Summit to explore the latest strategies in immunogenicity risk assessment, preclinical and clinical development, and bioassay design and analysis. Discover how to harness the immune system for therapeutic benefit through cutting-edge case studies, novel insights, and innovative approaches.